Ilyang Pharmaceutical Co.,Ltd (KRX: 007570)
South Korea
· Delayed Price · Currency is KRW 11,150
-70 (-0.62%)
Nov 15, 2024, 3:30 PM KST
Ilyang Pharmaceutical Co.,Ltd Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 199,949 | 281,258 | 349,981 | 510,655 | 1,197,901 | 410,527 | Upgrade
|
| Market Cap Growth | -25.91% | -19.64% | -31.46% | -57.37% | 191.80% | -17.82% | Upgrade
|
| Enterprise Value | 313,174 | 394,941 | 436,337 | 605,360 | 1,322,774 | 552,846 | Upgrade
|
| Last Close Price | 11100.00 | 15650.00 | 19161.53 | 27568.46 | 64205.98 | 21960.22 | Upgrade
|
| PE Ratio | - | - | 18.50 | 34.90 | 107.55 | 40.07 | Upgrade
|
| Forward PE | - | 49.90 | 49.90 | 49.90 | 49.90 | 49.90 | Upgrade
|
| PS Ratio | 0.54 | 0.76 | 0.91 | 1.38 | 3.49 | 1.26 | Upgrade
|
| PB Ratio | 0.87 | 1.07 | 1.20 | 1.88 | 4.89 | 1.84 | Upgrade
|
| P/TBV Ratio | 1.03 | 1.27 | 1.53 | 2.33 | 5.92 | 2.14 | Upgrade
|
| P/FCF Ratio | 10.60 | 21.16 | 13.54 | 9.44 | 25.32 | 12.07 | Upgrade
|
| P/OCF Ratio | 7.20 | 14.51 | 11.69 | 7.62 | 20.84 | 11.34 | Upgrade
|
| EV/Sales Ratio | 0.86 | 1.07 | 1.14 | 1.63 | 3.85 | 1.70 | Upgrade
|
| EV/EBITDA Ratio | 14.82 | 10.28 | 8.16 | 11.28 | 28.29 | 12.98 | Upgrade
|
| EV/EBIT Ratio | 37.08 | 15.92 | 10.80 | 14.76 | 38.79 | 17.00 | Upgrade
|
| EV/FCF Ratio | 16.60 | 29.71 | 16.88 | 11.19 | 27.96 | 16.25 | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.32 | 0.29 | 0.38 | 0.42 | 0.58 | Upgrade
|
| Debt / EBITDA Ratio | 2.74 | 2.22 | 1.60 | 1.90 | 2.20 | 3.02 | Upgrade
|
| Debt / FCF Ratio | 5.18 | 6.40 | 3.32 | 1.89 | 2.18 | 3.78 | Upgrade
|
| Asset Turnover | 0.76 | 0.77 | 0.77 | 0.80 | 0.78 | 0.75 | Upgrade
|
| Inventory Turnover | 2.32 | 2.77 | 3.28 | 3.72 | 3.17 | 2.83 | Upgrade
|
| Quick Ratio | 0.49 | 0.51 | 0.71 | 0.76 | 0.60 | 0.58 | Upgrade
|
| Current Ratio | 0.88 | 0.92 | 1.07 | 1.03 | 0.92 | 0.95 | Upgrade
|
| Return on Equity (ROE) | 1.37% | 0.04% | 11.26% | 10.05% | 9.21% | 9.06% | Upgrade
|
| Return on Assets (ROA) | 3.00% | 3.24% | 5.09% | 5.49% | 4.86% | 4.67% | Upgrade
|
| Return on Capital (ROIC) | 3.95% | 4.27% | 6.72% | 7.10% | 6.10% | 5.76% | Upgrade
|
| Earnings Yield | 0.29% | -0.91% | 5.50% | 2.82% | 0.91% | 2.43% | Upgrade
|
| FCF Yield | 9.44% | 4.73% | 7.39% | 10.60% | 3.95% | 8.29% | Upgrade
|
| Dividend Yield | 1.35% | 0.96% | - | - | - | - | Upgrade
|
| Payout Ratio | 685.90% | - | 20.49% | 61.00% | 45.05% | 58.24% | Upgrade
|
| Buyback Yield / Dilution | 0.58% | 0.59% | 0.44% | - | - | 0.29% | Upgrade
|
| Total Shareholder Return | 1.92% | 1.55% | 0.44% | - | - | 0.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.